[Activity of antithrombin III in the blood of patients with bladder cancer].
The activity of antithrombin III (AT III) in the blood of patients with bladder carcinoma was examined. It was shown an increase of AT III activity in comparison with control group. The changes of AT III activity in the blood of patients with bladder carcinoma can be the symptoms of an increased risk of haemorrhagic or thromboembolic complications.
Zietek
Z
Z
Katedry i Kliniki Urologii, Bydgoszczy.
Iwan-Zietek
I
I
Kotschy
M
M
Wiśniewska
E
E
Tyloch
F
F
D000368:Aged; D000369:Aged, 80 and over; D000990:Antithrombin III / Q000032:analysis*; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D006470:Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D013923:Thromboembolism / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D001745:Urinary Bladder Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000150:complications
D015415:Biomarkers; D000990:Antithrombin III